Inflammatory pathways such as NF-κB, Jun N-terminal kinase (JNK), and inflammasomes have been shown to play a significant role in the development of MetS pathophysiology [164,165,166,167,168]. This evidence concerns the gene MAPK8 and metabolic syndrome.